STANDEX INTERNATIONAL CORP/DE/
Business
Standex International Corporation is a diversified industrial manufacturer with leading positions in engineered components and solutions across multiple markets. The company operates through five reportable segments: Electronics (sensing and switching technologies, transformers, magnetic components), Engineering Technologies (metal-formed solutions for aerospace and defense), Scientific (temperature-controlled equipment for medical and pharmaceutical applications), Engraving (custom surface textures and tooling), and Specialty Solutions (refrigerated display cases and hydraulic cylinders). Products are sold globally to OEMs, Tier 1 manufacturers, and distributors across appliances, aerospace, defense, medical, food service, and industrial equipment markets.
Summary from 10-K filed 2025-08-04
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Net sales | 790 | 721 | 741 | 735 | 656 | |
| Cost of sales | −475 | −439 | −456 | −465 | −415 | |
| Gross profit | 315 | 282 | 285 | 270 | 241 | |
| Selling, general and administrative expenses | 193 | 170 | 172 | 170 | 163 | |
| Restructuring costs | 7 | 8 | 4 | 4 | 3 | |
| (Gain) loss on sale of business | 0 | −274,000 | −62 | 0 | 15 | |
| Acquisition related costs | 21 | 3 | 600,000 | 2 | 931,000 | |
| Other operating (income) expense, net | 0 | 110,000 | −611,000 | 6 | 0 | |
| Income from operations | 94 | 102 | 171 | 88 | 59 | |
| Interest expense | 24 | 5 | 5 | 6 | 6 | |
| Other non-operating (income) expense, net | 808,000 | 2 | 2 | 1 | 473,000 | |
| Income from continuing operations before income taxes | 69 | 95 | 164 | 81 | 53 | |
| Provision for income taxes | −11 | −22 | −25 | −20 | −14 | |
| Income from continuing operations | 58 | 74 | 139 | — | — | |
| Income (loss) from discontinued operations, net of tax | −42,000 | −517,000 | −161,000 | −89,000 | −2 | |
| Net income | 58 | 73 | 139 | — | — | |
| Less: net income attributable to redeemable noncontrolling interest | 2 | 0 | 0 | — | — | |
| Net income attributable to Standex International Corporation | 56 | 73 | 139 | 61 | 36 | |
| Income (loss) from continuing operations (in dollars per share) | 4.68 | 6.26 | 11.78 | 5.13 | 3.17 | |
| Income (loss) from discontinued operations (in dollars per share) | 0 | −0.04 | −0.01 | 0 | −0.17 | |
| Total (in dollars per share) | 4.68 | 6.22 | 11.77 | 5.13 | 3 | |
| Income (loss) from continuing operations (in dollars per share) | 4.64 | 6.18 | 11.59 | 5.07 | 3.14 | |
| Income (loss) from discontinued operations (in dollars per share) | 0 | −0.04 | −0.01 | −0.01 | −0.17 | |
| Total (in dollars per share) | 4.64 | 6.14 | 11.58 | 5.06 | 2.97 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 105 | 154 | 196 | 105 | 136 | |
| Accounts receivable, net | 173 | 121 | 123 | 117 | 110 | |
| Inventories | 130 | 87 | 99 | 105 | 92 | |
| Prepaid expenses and other current assets | 14 | 22 | 34 | 45 | 24 | |
| Contract assets | 59 | 45 | 31 | 25 | — | |
| Total current assets | 481 | 430 | 483 | 379 | 374 | |
| Property, plant and equipment, net | 160 | 135 | 131 | 129 | 133 | |
| Intangible assets, net | 226 | 79 | 76 | 86 | 99 | |
| Goodwill | 610 | 281 | 265 | 268 | 278 | |
| Deferred tax asset | 12 | 17 | 15 | 8 | 10 | |
| Operating lease right-of-use-asset | 48 | 37 | 33 | 39 | 37 | |
| Other non-current assets | 30 | 26 | 22 | 26 | 31 | |
| Total non-current assets | 1,086 | 575 | 542 | 555 | 588 | |
| Total assets | 1,567 | 1,005 | 1,025 | 934 | 962 | |
| Accounts payable | 88 | 63 | 69 | 75 | 75 | |
| Accrued liabilities | 63 | 57 | 62 | 68 | 62 | |
| Income taxes payable | 16 | 8 | 10 | 8 | 7 | |
| Total current liabilities | 167 | 128 | 141 | 151 | 144 | |
| Long-term debt | 553 | 149 | 173 | 175 | 199 | |
| Operating lease long-term liabilities | 40 | 31 | 26 | 31 | 29 | |
| Accrued pension and other non-current liabilities | 68 | 76 | 77 | 78 | 84 | |
| Total non-current liabilities | 660 | 256 | 277 | 284 | 312 | |
| Contingencies (Note 12) | — | — | — | — | — | |
| Redeemable noncontrolling interest | 28 | 0 | — | — | — | |
| Common stock, par value $1.50 per share - 60,000,000 shares authorized, 27,984,278 issued, 11,992,116 and 11,761,700 shares outstanding in 2025 and 2024 | 42 | 42 | 42 | 42 | 42 | |
| Additional paid-in capital | 136 | 106 | 101 | 91 | 81 | |
| Retained earnings | 1,127 | 1,086 | 1,027 | 901 | 852 | |
| Accumulated other comprehensive loss | −165 | −183 | −158 | −153 | −116 | |
| Treasury shares (15,992,162 shares in 2025 and 16,222,578 shares in 2024) | −428 | −430 | −404 | −382 | — | |
| Total stockholders' equity | 712 | 622 | 607 | 499 | 506 | |
| Total liabilities and stockholders' equity | 1,567 | 1,005 | 1,025 | 934 | 962 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Income (loss) from discontinued operations | −42,000 | −517,000 | −161,000 | — | — | |
| Depreciation and amortization | 35 | 28 | 28 | 30 | 33 | |
| Stock-based compensation | 9 | 10 | 12 | 11 | 8 | |
| Gain on sale of real estate and equipment | 102,000 | 0 | −199,000 | −456,000 | 0 | |
| Non-cash portion of restructuring charge | 10,000 | 151,000 | −444,000 | 2 | −489,000 | |
| Deferred income taxes | −10 | −3 | −7 | −2 | 836,000 | |
| Life insurance benefit | −223,000 | 0 | 0 | −193,000 | 0 | |
| Contributions to defined benefit plans | −8 | −10 | −451,000 | −535,000 | −8 | |
| Accounts receivables, net | −14 | 16 | −10 | −12 | −6 | |
| Inventories | −16 | 17 | −912,000 | −18 | −8 | |
| Prepaid expenses and other assets | 20 | 2 | −6 | −9 | −8 | |
| Accounts payable | 14 | −14 | −3 | 6 | 18 | |
| Accrued liabilities, pension and other liabilities | −24 | −22 | −5 | 2 | 5 | |
| Income taxes payable | 5 | −5 | 7 | 8 | −6 | |
| Net cash provided by operating activities from continuing operations | 70 | 93 | 91 | 78 | 82 | |
| Net cash provided by (used for) operating activities from discontinued operations | −52,000 | −690,000 | 33,000 | −421,000 | 2 | |
| Net cash provided by operating activities | 70 | 93 | 91 | 78 | 84 | |
| Expenditures for property, plant and equipment | −28 | −20 | −24 | −24 | −22 | |
| Expenditures for acquisitions, net of cash acquired | −479 | −49 | 0 | −13 | −27 | |
| Expenditures for executive life insurance policies | −132,000 | −270,000 | −278,000 | −248,000 | −243,000 | |
| Proceeds from sale of business | 0 | 8 | 67 | 0 | 12 | |
| Proceeds from sale of real estate and equipment | 438,000 | 0 | 2 | 2 | 117,000 | |
| Proceeds withdrawn from life insurance policies | 3 | 0 | 0 | 5 | 0 | |
| Other investing activity | 0 | 0 | −3 | −721,000 | −1 | |
| Net cash provided by (used for) investing activities from continuing operations | −503 | −62 | 42 | −31 | −39 | |
| Net cash provided by investing activities from discontinued operations | 0 | 0 | 0 | 0 | 0 | |
| Net cash (used for) investing activities | −503 | −62 | 42 | −31 | −39 | |
| Proceeds from borrowings | 792 | 0 | 225 | — | — | |
| Payments of debt | −389 | −25 | −226 | — | — | |
| Contingent consideration payment | 0 | 0 | −1 | −2 | −356,000 | |
| Activity under share-based payment plans | 2 | 2 | 1 | 1 | 1 | |
| Purchase of treasury stock and other | −10 | −32 | −26 | −31 | −21 | |
| Cash dividends paid | −15 | −14 | −13 | −12 | −11 | |
| Net cash provided by (used for) financing activities | 380 | −69 | −40 | −69 | −32 | |
| Effect of exchange rate changes on cash | 4 | −3 | −1 | −9 | 5 | |
| Net change in cash and cash equivalents | −50 | −42 | 91 | −32 | 18 | |
| Interest | 21 | 4 | 4 | 5 | 5 | |
| Income taxes, net of refunds | 28 | 28 | 26 | 18 | 17 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is STANDEX INTERNATIONAL CORP/DE/'s CIK number?
STANDEX INTERNATIONAL CORP/DE/'s SEC CIK number is 0000310354 (310354). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find STANDEX INTERNATIONAL CORP/DE/'s SEC filings?
All of STANDEX INTERNATIONAL CORP/DE/'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did STANDEX INTERNATIONAL CORP/DE/ last report earnings?
STANDEX INTERNATIONAL CORP/DE/ (SXI) most recently filed an earnings 8-K with the SEC on May 5, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001437749-26-014956). This is STANDEX INTERNATIONAL CORP/DE/'s most recent earnings filing of record — not a forecast of its next earnings date.
What is STANDEX INTERNATIONAL CORP/DE/'s most recent earnings 8-K?
STANDEX INTERNATIONAL CORP/DE/'s latest earnings 8-K (Item 2.02) was filed May 5, 2026 under accession 0001437749-26-014956. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View STANDEX INTERNATIONAL CORP/DE/'s latest earnings 8-K →
Look up any company's CIK number →